BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11179059)

  • 21. Vasomotor control in mice overexpressing human endothelial nitric oxide synthase.
    van Deel ED; Merkus D; van Haperen R; de Waard MC; de Crom R; Duncker DJ
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1144-53. PubMed ID: 17496213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide inhibits alpha2-adrenoceptor-mediated endothelium-dependent vasodilation.
    Thorin E; Huang PL; Fishman MC; Bevan JA
    Circ Res; 1998 Jun; 82(12):1323-9. PubMed ID: 9648729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular smooth muscle cell-directed overexpression of heme oxygenase-1 elevates blood pressure through attenuation of nitric oxide-induced vasodilation in mice.
    Imai T; Morita T; Shindo T; Nagai R; Yazaki Y; Kurihara H; Suematsu M; Katayama S
    Circ Res; 2001 Jul; 89(1):55-62. PubMed ID: 11440978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice.
    Pojoga LH; Adamová Z; Kumar A; Stennett AK; Romero JR; Adler GK; Williams GH; Khalil RA
    Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H1776-88. PubMed ID: 20363891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo.
    Moncada S; Rees DD; Schulz R; Palmer RM
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2166-70. PubMed ID: 1848694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.
    Mollnau H; Wendt M; Szöcs K; Lassègue B; Schulz E; Oelze M; Li H; Bodenschatz M; August M; Kleschyov AL; Tsilimingas N; Walter U; Förstermann U; Meinertz T; Griendling K; Münzel T
    Circ Res; 2002 Mar; 90(4):E58-65. PubMed ID: 11884382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of the endothelial nitric oxide synthase-soluble guanylate cyclase pathway is normalized by insulin in the aorta of diabetic rat.
    Zanetti M; Barazzoni R; Stebel M; Roder E; Biolo G; Baralle FE; Cattin L; Guarnieri G
    Atherosclerosis; 2005 Jul; 181(1):69-73. PubMed ID: 15939056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
    Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
    Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the role of the NO-cGMP pathway on YC-1 and DEA/NO effects on thoracic aorta smooth muscle responses in a rat preeclampsia model.
    Turgut NH; Temiz TK; Turgut B; Karadas B; Parlak M; Bagcivan I
    Can J Physiol Pharmacol; 2013 Oct; 91(10):797-803. PubMed ID: 24144050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenylephrine activates eNOS Ser 1177 phosphorylation and nitric oxide signaling in renal hypertensive rat aorta.
    Silva BR; Pernomian L; Grando MD; Bendhack LM
    Eur J Pharmacol; 2014 Sep; 738():192-9. PubMed ID: 24886887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase.
    Venema RC; Venema VJ; Ju H; Harris MB; Snead C; Jilling T; Dimitropoulou C; Maragoudakis ME; Catravas JD
    Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H669-78. PubMed ID: 12676772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cGMP-dependent protein kinase in regulation of basal tone and in nitroglycerin- and nitric-oxide-induced relaxation in porcine coronary artery.
    Qin X; Zheng X; Qi H; Dou D; Raj JU; Gao Y
    Pflugers Arch; 2007 Sep; 454(6):913-23. PubMed ID: 17377806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
    Bouallegue A; Daou GB; Srivastava AK
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.
    Bexis S; Vandeputte C; McCormick PA; Docherty JR
    Eur J Pharmacol; 2004 Sep; 499(3):325-33. PubMed ID: 15381055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation.
    Mink SN; Kasian K; Santos Martinez LE; Jacobs H; Bose R; Cheng ZQ; Light RB
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1724-35. PubMed ID: 18263714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered vascular function in fetal programming of hypertension.
    Lamireau D; Nuyt AM; Hou X; Bernier S; Beauchamp M; Gobeil F; Lahaie I; Varma DR; Chemtob S
    Stroke; 2002 Dec; 33(12):2992-8. PubMed ID: 12468802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide preconditioning regulates endothelial monolayer integrity via the heat shock protein 90-soluble guanylate cyclase pathway.
    Antonova GN; Snead CM; Antonov AS; Dimitropoulou C; Venema RC; Catravas JD
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H893-903. PubMed ID: 17012359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early changes in vasoreactivity after simulated microgravity are due to an upregulation of the endothelium-dependent nitric oxide/cGMP pathway.
    White AR; Ryoo S; Bugaj L; Attarzadeh DO; Thiyagarajan S; Chen K; Attwater S; Abbot B; Li D; Champion HC; Shoukas AA; Nyhan D; Hare JM; Berkowitz DE; Tuday EC
    Eur J Appl Physiol; 2010 Sep; 110(2):395-404. PubMed ID: 20512503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasorelaxant Effect of Novel Nitric Oxide-Hydrogen Sulfide Donor Chalcone in Isolated Rat Aorta: Involvement of cGMP Mediated sGC and Potassium Channel Activation.
    Sherikar A; Dhavale R; Bhatia M
    Curr Mol Pharmacol; 2020; 13(2):126-136. PubMed ID: 31654520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial natriuretic peptide accounts for increased cGMP in hypoxia-induced hypertensive rat lungs.
    Muramatsu M; Tyler RC; Gutkowska J; Klinger JR; Hill NS; Rodman DM; McMurtry IF
    Am J Physiol; 1997 Jun; 272(6 Pt 1):L1126-32. PubMed ID: 9227514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.